Enovis share price logo

Enovis

NYSE: ENOV

Small Cap

$17.77

-0.28

(-1.55%)

as on

Enovis Stock Performance

as on October 3, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $17.68
    $18.27
    downward going graph

    0.51%

    Downside

    2.81%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $17.30
    $34.28
    downward going graph

    2.64%

    Downside

    92.91%

    Upside

    downward going graph

Enovis share price movements today

Previous Close
$18.05
Open
$18.03
Volume
1.1M
Market Cap
$1.0B
Day's Low - High
$17.68 - $18.27
52 Week Low - High
$17.30 - $34.28

Enovis Historical Returns

1 Month Return
-8.4 %
3 Month Return
-21.02 %
1 Year Return
-44.5 %
3 Year Return
-64.66 %
5 Year Return
-62.26 %

Enovis Stock Fundamentals & Key Indicators

Check Enovis market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.0B

EPS (TTM)

-19.4

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

1.53%

PE Ratio (TTM)

-0.94

Industry PE ratio

-7.81

PEG Ratio

0.02

EBITDA

-716.9M

Revenue (TTM)

2.3B

Profit Margin

57.43%

Return On Equity TTM

-68.17%

Enovis vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Enovis with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$1.0B-62.26%-0.9457.43%0.00%
Buy$49.1B-24.16%49.0577.98%0.00%
Buy$110.4B-32.15%21.1666.69%3.31%
StrongBuy$105.6B2.69%28.1065.17%1.29%
StrongBuy$171.0B-16.82%31.3056.80%2.56%

Stock Returns calculator for Enovis Stock including INR - Dollar returns

The Enovis stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Enovis investment value today

Current value as on today

₹60,228

Returns

-₹39,772

(-39.77%)

Returns from Enovis Stock

-₹44,503 (-44.5%)

Dollar Impact

₹4,731 (+4.73%)

Analyst Recommendation on Enovis Stock

Based on 6 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 6 analysts, 83.33333333333334% of analysts recommend a 'BUY' rating for Enovis. Average target price of $38.33

Enovis Share Price Target

Get share price movements and forecasts by analysts on Enovis.

What analysts predicted

53.64%UPSIDE

Target Price

$38.33

Current Price

$17.77

Analyzed by

6 Analysts

High

$52

Target

$38.33

Low

$28

Enovis target price $38.33, a slight upside of 53.64% compared to current price of $17.77. According to 6 analysts rating.

Indian Investors' Interest in Enovis Stock

Search interest for Enovis Stock has increased by 184% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:184% versus previous 30 day period

Enovis Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
516
525
505
560
558
564
548
575
589
582
Gross Profit
297
288
327
307
332
334
286
349
323
359
Operating Income
-35
-44
-31
-664
-42
-16
9
48
20
17
EBITDA
14
55
39
-590
23
55
-471
-425
93
86
Interest Expense
19
16
11
9
9
9
20
7
19
8
Depreciation
73
65
71
74
71
71
74
77
73
71
Income Before Tax
-79
-27
-42
-673
-57
-25
-566
-509
0
7
Income Tax Expense
-7
-8
-9
29
-1
10
4
9
9
8
Net Income
-71
-18
-31
-703
-55
-36
-571
-520
-8
-1
Net Profit Margin
57.70%
55.01%
56.70%
54.82%
59.45%
59.29%
52.23%
60.69%
54.92%
61.64%

Enovis Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
3,300
3,666
3,327
1,120
1,426
1,563
1,707
2,107
2,248
Gross Profit
1,029
1,132
1,401
603
777
869
990
1,180
1,345
Operating Income
29
236
203
-66
-62
-71
-65
-775
-18
EBITDA
160
330
406
180
170
241
169
-481
-830
Interest Expense
40
49
119
52
29
24
19
57
34
Depreciation
123
141
236
246
262
219
217
284
294
Income Before Tax
-11
182
50
-119
-121
-2
-67
-822
-1,159
Income Tax Expense
42
0
31
-44
-19
36
-13
4
22
Net Income
151
140
-527
42
71
-13
-33
-825
-1,184
Net Profit Margin
31.19%
30.89%
42.11%
53.86%
54.53%
55.62%
58.04%
56.02%
59.84%

Enovis Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-71
-18
-31
-703
-55
-36
-570
-503
-8
-1
Operating Cash Flow
-36
7
53
88
-1
47
82
88
23
75
Investing Cash Flow
-797
-41
-58
-57
-60
-49
-56
-12
-53
-45
Financing Cash Flow
864
2
0
-20
51
6
-36
-72
26
-50
Change in Cash
29
-31
-3
8
-9
5
-10
2
-3
-20

Enovis Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
169
154
-517
45
76
-11
-33
-824
-1,183
Operating Cash Flow
218
226
130
301
356
-55
134
113
217
Investing Cash Flow
89
-167
-1,632
-175
-320
-176
-242
-955
-179
Financing Cash Flow
-280
-47
1,369
-131
584
-465
127
846
-52
Change in Cash
40
-17
-135
-8
618
-695
20
3
-11

Global Institutional Holdings in Enovis

Check out the Institutions with significant holdings in Enovis.

Funds
Holdings
iShares
14.48%
Vanguard
9.47%
VANGUARD INDEX FUNDS
8.01%
American Century Capital Portfolios, Inc.
4.64%
Avantis
4.38%

Insights on Enovis

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, -571.14M → -1.19M (in $), with an average increase of 2162.1% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp has given 10.5% return, outperforming this stock by 55.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Edwards Lifesciences Corp has given 19.5% return, outperforming this stock by 84.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, ENOV stock has moved down by -64.6%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 589.15M → 582.78M (in $), with an average decrease of 1.1% per quarter

About Enovis

Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.
OrganisationEnovis
Headquarters2711 Centerville Road, Wilmington, DE, 19808, US
IndustryMedical - Devices
CEODamien McDonald

Key Management of Enovis

Name

Title

Mr. Phillip Benjamin Berry

Senior VP & CFO

Ms. Patricia A. Lang

Advisor

Mr. Louie Vogt

Group President of Reconstructive

Mr. Bradley J. Tandy J.D.

Senior VP & Chief Legal Officer

Ms. Laura Singleton

Senior VP & Chief Human Resources Officer

Mr. Damien McDonald

CEO & Director

Mr. Terry D. Ross

Group President Prevention & Recovery

Mr. John Kleckner

VP, Controller & Chief Accounting Officer

Mr. Oliver Engert

Chief Administrative Officer

Mr. Kyle William Rose

Vice President of Investor Relations

FAQs

What is Enovis share price today?

Enovis share price today is $17.77 as on at the close of the market. Enovis share today touched a day high of $18.27 and a low of $17.68.

What is the 52 week high and 52 week low for Enovis share?

Enovis share touched a 52 week high of $34.28 on and a 52 week low of $17.30 on . Enovis stock price today i.e. is closed at $17.77,which is 48.16% down from its 52 week high and 2.72% up from its 52 week low.

What is Enovis's market capitalisation today?

Enovis market capitalisation is $0.00T as on .

How to invest in Enovis Stock (ENOV) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Enovis on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Enovis Stock (ENOV) from India?

Indian investors can start investing in Enovis (ENOV) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Enovis stock (as per the Rupee-Dollar exchange rate as on ). Based on Enovis share’s latest price of $17.77 as on October 3, 2026 at 8:45 am IST, you will get 0.5627 shares of Enovis. Learn more about fractional shares .

What are the returns that Enovis has given to Indian investors in the last 5 years?

Enovis stock has given -62.26% share price returns and 28.69% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?